Accessibility: Skip TopNav
Nebokitug Treatment for 48 Weeks Stabilizes Risk of Disease Progression as Determined by ELF Score
Nebokitug Treatment for 48 Weeks Stabilizes Risk of Disease Progression as Determined by ELF Score
Format
PNG
Quelle:
Chemomab Therapeutics Ltd.
Downloads
Originalgröße
Groß
Mittel
Klein